Literature DB >> 14614886

Staging and classification of gestational trophoblastic disease.

Barry William Hancock1.   

Abstract

Many staging, classification and prognostic systems have been applied to persistent trophoblastic disease. Also terminology has differed across the world, together with criteria for treatment. Consequently it has been difficult to compare results from different centres and it is likely that some patients have been either under or over treated, resulting in increased chemoresistance or treatment toxicity, respectively. There is a need for globally agreed guidelines. This chapter addresses developments leading up to the recent publication of an internationally agreed staging/prognostic scoring system.

Entities:  

Mesh:

Year:  2003        PMID: 14614886     DOI: 10.1016/s1521-6934(03)00073-7

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  7 in total

1.  Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.

Authors:  Yang Weng; Yuanyuan Liu; Chitapa Benjoed; Xiaodong Wu; Sangsang Tang; Xiao Li; Xing Xie; Weiguo Lu
Journal:  J Zhejiang Univ Sci B       Date:  2022-03-15       Impact factor: 3.066

2.  Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.

Authors:  Raymond J Osborne; Virginia L Filiaci; Julian C Schink; Robert S Mannel; Kian Behbakht; James S Hoffman; Nick M Spirtos; John K Chan; John A Tidy; David S Miller
Journal:  Obstet Gynecol       Date:  2016-09       Impact factor: 7.661

3.  Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.

Authors:  Y K Eysbouts; P B Ottevanger; L F A G Massuger; J IntHout; D Short; R Harvey; B Kaur; N J Sebire; N Sarwar; F C G J Sweep; M J Seckl
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

Review 4.  Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management.

Authors:  Sunita Dhanda; Subhash Ramani; Meenkashi Thakur
Journal:  Radiol Res Pract       Date:  2014-07-13

5.  Clinical analysis and management of gestational trophoblastic diseases: a 90 cases study.

Authors:  Ben Temime Riadh; Chechia Abdellatif; Hannachi Wissal; Attia Leila; Makhlouf Taher; Koubaa Abdelhamid
Journal:  Int J Biomed Sci       Date:  2009-12

6.  NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges.

Authors:  Rima Slim; Evan P Wallace
Journal:  Front Immunol       Date:  2013-08-20       Impact factor: 7.561

7.  Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study.

Authors:  Y M Hoeijmakers; Fcgj Sweep; Car Lok; P B Ottevanger
Journal:  BJOG       Date:  2020-03-31       Impact factor: 6.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.